The New Foe and Old Friends : Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?

Errataetall:

CommentOn: Gastroenterology. 2020 Sep;159(3):944-955.e8. - PMID 32442562

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Gastroenterology - Vol. 160, No. 6 (2021), p. 2192-2193

Language:

English

Contributors:

Peng, Ye
Zhao, Jincun
Tun, Hein M

Links:

Volltext

Keywords:

*COVID-19
*Gastrointestinal Microbiome
*Microbiota
Comment
Friends
Hospitalization
Humans
Letter
SARS-CoV-2

Notes:

Date Completed 06.05.2021

Date Revised 06.05.2021

published: Print-Electronic

CommentOn: Gastroenterology. 2020 Sep;159(3):944-955.e8. - PMID 32442562

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1053/j.gastro.2020.08.048

PMID:

32877709

PPN (Catalogue-ID):

NLM31545217X